We serve 3-Furoic acid CAS:488-93-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 3-Furoic acid
CAS.NO:488-93-7
Molecular Formula:C5H4O3
Molecular Weight:112.08300
Synonyms:
3-Furancarboxylic Acid
furan-3-carboxylic acid
3-Furoic acid
Physical and Chemical Properties:
Density: 1.322 g / cm3
Boiling point: 229.6ºC at 760 mmHg
Melting point: 120-122 ° C (lit.)
Flash point: 92.7ºC
Refractive index: 1.513
Specification:
Appearance:White to yellow powder
Purity:≥99.0%
Loss on drying:≤0.5%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:Applicationd for the synthesis of intermediates, photosensitive materials, food additives, drugs and pesticides.
Contact us for information like 3-Furoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Furoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,furan-3-carboxylic acid Use and application,furan-3-carboxylic acid technical grade,usp/ep/jp grade.
Related News: Such was the apparent demand sparked by the notice that the compound formula sold out on some stores on China’s e-commerce platform Taobao.N,N'-Carbonyldiimidazole manufacturer Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.phloroglucinol supplier Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.Ethyl 2,4,5-trifluorobenzoylacetate vendor China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.
